HF
ANGO icon

HRT Financial’s AngioDynamics ANGO Stock Holding History

HRT Financial’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,478
Closed -$150K – 3129
2025
Q3 		$150K Buy
+13,478
New +$130K ﹤0.01% 2466
2024
Q1 		– Sell
-134,360
Closed -$1.05M – 2267
2023
Q4 		$1.05M Sell
134,360
-216,961
-62% -$1.5M 0.01% 956
2023
Q3 		$2.57M Buy
351,321
+228,938
+187% +$1.9M 0.03% 520
2023
Q2 		$1.28M Buy
+122,383
New +$1.18M 0.01% 802
2022
Q1 		– Sell
-43,614
Closed -$1.2M – 3049
2021
Q4 		$1.2M Buy
43,614
+8,778
+25% +$242K 0.01% 967
2021
Q3 		$903K Sell
34,836
-23,500
-40% -$628K 0.01% 1431
2021
Q2 		$1.58M Buy
58,336
+12,682
+28% +$310K 0.01% 743
2021
Q1 		$1.07M Buy
+45,654
New +$923K 0.01% 1062

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KK
Kotler Kevin $427M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HRT Financial's ANGO Position: Q4 2025 in Review

HRT Financial sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 13,478 shares — an estimated $150K sold.

HRT Financial first reported a position in ANGO in Q1 2021 and held it in 8 quarters. The position peaked at $2.57M in Q3 2023. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.

  • HRT Financial reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 13,478 AngioDynamics shares in Q4 2025, an estimated $150K.
  • HRT Financial first reported a position in AngioDynamics in Q1 2021 and held it in 8 quarters.
  • HRT Financial's AngioDynamics position peaked at $2.57M in Q3 2023.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.